Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...

Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...

Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with widespread misinformation about treatment options, create significant barriers ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

The temporary spending bill that the House and Senate approved last night will keep the federal government operating through ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...